Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (351-360 of 491) with videos related to

Pageof 50
Sort By:
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Radiology|November 20, 2019
Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?Nina Bastati, Lucian Beer, Mattias Mandorfer, et al.
Plos One|January 10, 2018
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experienceTheresa Bucsics, Maria Schoder, Magdalena Diermayr, et al.
Alimentary Pharmacology & Therapeutics|March 14, 2024
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver diseaseNina Dominik, Bernhard Scheiner, Alberto Zanetto, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 12, 2023
GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2<sup>-/-</sup> Mice Via Activation of NR4a1/Nur77 in Hepatic Stellate Cells and Intestinal FXR SignalingClaudia D Fuchs, Thierry Claudel, Veronika Mlitz, et al.
Journal of Hepatology|March 13, 2024
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis deltaMathias Jachs, Lisa Sandmann, Lukas Hartl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 5, 2017
Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practiceTheresa Bucsics, Maria Schoder, Nicolas Goeschl, et al.
International Journal of Molecular Sciences|March 20, 2020
Recent Advances in Practical Methods for Liver Cell Biology: A Short OverviewSandra Torres, Zeinab Abdullah, Maximilian J Brol, et al.
Pageof 50

Showing results (351-360 of 491) with videos related to

Sort By:
Pageof 50
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Radiology|November 20, 2019
Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?Nina Bastati, Lucian Beer, Mattias Mandorfer, et al.
Plos One|January 10, 2018
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experienceTheresa Bucsics, Maria Schoder, Magdalena Diermayr, et al.
Alimentary Pharmacology & Therapeutics|March 14, 2024
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver diseaseNina Dominik, Bernhard Scheiner, Alberto Zanetto, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 12, 2023
GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2<sup>-/-</sup> Mice Via Activation of NR4a1/Nur77 in Hepatic Stellate Cells and Intestinal FXR SignalingClaudia D Fuchs, Thierry Claudel, Veronika Mlitz, et al.
Journal of Hepatology|March 13, 2024
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis deltaMathias Jachs, Lisa Sandmann, Lukas Hartl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 5, 2017
Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practiceTheresa Bucsics, Maria Schoder, Nicolas Goeschl, et al.
International Journal of Molecular Sciences|March 20, 2020
Recent Advances in Practical Methods for Liver Cell Biology: A Short OverviewSandra Torres, Zeinab Abdullah, Maximilian J Brol, et al.
Pageof 50